AstraZeneca rises after it reportedly made $10 billion bid for obesity drugmaker Rhythm

RYTM•2026-11-05

AstraZeneca reportedly offered about $10 billion for Rhythm Pharmaceuticals, including up to $134 per share plus payments tied to milestone achievements. AstraZeneca shares rose 1.3%.

AstraZeneca rises after it reportedly made $10 billion bid for obesity drugmaker Rhythm

1. Reported bid

Related News

High debt, rise of non-banks risk tying ECB's hands, Schnabel says

BNP Paribas sets R 6.66 million redemption payment for February 1, 2027

Goldilocks or gridlock?

Gold rallies on softer dollar, easing yields after US midterm results

Sibanye-Stillwater adds secondary listing on A2X